Volume 14, Issue 3 (May & Jun 2023)                   BCN 2023, 14(3): 317-322 | Back to browse issues page

XML Print

1- Institute for Cognitive Science Studies, Tehran, Iran.
2- Department of Psychology, Faculty of Humanities, Tarbiat Modares University, Tehran, Iran.
3- Department of Brain and Cognitive Science, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Tehran, Iran.
Introduction: Sexual addiction is known as a disorder that afflicts a person with difficulty in controlling or delaying sexual behaviors. To prevent social, physical, and psychological consequences, validated screening tests are needed to diagnose this disorder. One of these tests is established by Carnes with the name of sexual addiction screening test-revised (SAST-R). In this study, SAST-R has been translated and verified in the Persian language.
Methods: The original screening test was translated into the Persian language and also back-translated for matching by two separate expert teams. The data was collected through an online survey of 1268 participants who were in the age range of 18 to 65 years (Mean±SD 29.44±6.90), and 56.1% and 43.9% of the population were women and men, respectively. Three questionnaires, including the SAST-R, the hypersexual behavior consequences scale, and the Connor-Davidson resilience scale as the principal, convergent, and divergent tests were administered to the participants.
Results: The reliability of the test’s internal consistency (Cronbach α=0.883), split-half (Cronbach α=0.779), and Guttman (lambda coefficients were between 0.773 to 0.883) tests were used. In addition, 4 methods of content validity (sexual hyperactivity specialist approved), convergent structure validity (P<0.001, R=0.731), the validity of divergent structure (P<0.09, R=-0.132), and factor validity (comparative fit index=0.884, goodness of fit index=0.873, root mean square error of approximation=0.047) were measured and confirmed the validity of the test.
Conclusion: The Persian version of SAST-R is a reliable preclinical tool to assess the severity of sexual desire in patients.
Type of Study: Original | Subject: Clinical Neuroscience
Received: 2019/07/6 | Accepted: 2021/10/30 | Published: 2023/05/8

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.